Erectile Dysfunction: Clinical Trials

671 trials for Erectile Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

384 completed, 131 unknown, 57 recruiting, 29 not yet recruiting. 197 Not applicable, 111 Phase 3, 104 Phase 4, 86 Phase 2, 77 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable197Completed 74, Unknown 56, Recruiting 30, Withdrawn 12, Not yet recruiting 10, Terminated 8, Active not recruiting 5, Enrolling by invitation 2
Phase 3111Completed 79, Unknown 17, Recruiting 5, Terminated 4, Not yet recruiting 3, Active not recruiting 2, Withdrawn 1
Phase 4104Completed 80, Unknown 14, Recruiting 4, Withdrawn 4, Not yet recruiting 1, Terminated 1
Phase 286Completed 47, Unknown 16, Recruiting 10, Not yet recruiting 4, Terminated 4, Withdrawn 3, Active not recruiting 2
Phase 177Completed 53, Unknown 11, Not yet recruiting 5, Withdrawn 4, Recruiting 3, Terminated 1
Early Phase 13Active not recruiting 1, Terminated 1, Unknown 1

Follow Erectile Dysfunction: new trials by email Literature Review of Erectile Dysfunction trials Research Report on Erectile Dysfunction

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Male Pelvic Floor Muscle Rehabilitation Exercises
Male Pelvic Floor Rehabilitation #1 - Erectile Dysfunction, Urinary Incontinence
Not applicableNot yet recruitingDream Video LLC1002026-12-012026-10-07
Shockwave Therapy on Treating Erectile Dysfunction Following Nerve-sparing Radical Prostatectomy.
Low-Intensity Extracorporeal Shockwave Therapy, Standard of Care - Erectile Dysfunction
Not applicableNot yet recruitingUniversity of Manitoba802026-12-012026-09-30
Platelet-Rich Plasma for Erectile Dysfunction After Radical Prostatectomy
Autologous Platelet Rich Plasma, saline solution (placebo) - Erectile Dysfunction Following Radical Prostatectomy, Erectile Dysfunction
Not applicableRecruitingHerlev and Gentofte Hospital1002026-11-102026-11-06
IPP Placement & Intracavernosal Block
Exparel/bupivacaine mixture - Erectile Dysfunction (ED)
Phase 4Not yet recruitingWake Forest University Health Sciences1002026-11-012026-09-24
Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment
Sex Therapy, Pelvic Floor Physical Therapy, Vacuum Erection Device (VED) - Prostate Cancer, Urinary Incontinence
Not applicableRecruitingDuke University302026-11-012026-11-06
EECP for Erectile Dysfunction in Elderly Hypertensive Patients
Enhanced External Counterpulsation, Sham Enhanced External Counterpulsation - Hypertension, Erectile Dysfunction
Not applicableNot yet recruitingQilu Hospital of Shandong University1062026-10-012026-09-21
Assessment of Erectile Dysfunction and Coronary Artery Disease Severity
Selective Coronary Angiography - Erectile Dysfunction and Coronary Artery Disease
Not yet recruitingAssiut University1202026-10-012026-09-10
A Study to Evaluate Efficacy and Safety of HIP2602 in Erectile Dysfunction Patients
HIP2602 + HPP2602-2, HPP2602-1 + HPP2602-2, HGP1201 + HPP2602-1 - Erectile Dysfunction
Phase 3RecruitingHanmi Pharmaceutical Company Limited2252026-10-012026-10-27
Pudendal Atherosclerosis by IVUS-NIRS in Men With Coronary Artery Disease
Selective Pudendal Angiography, Pudendal IVUS-NIRS Imaging - Coronary Artery Disease, Erectile Dysfunction
Not applicableRecruitingHospital Central Militar602026-09-242026-10-02
The Purpose of This Study is to Evaluate the Efficacy and Safety of W2505.
W2505, W2505-P1, W2505-R - Erectile Dysfunctions
Phase 3Not yet recruitingGL Pharm Tech Corporation2282026-09-012026-10-05
Platelet-Rich Plasma Alone Versus PRP Plus Low-Intensity Shock Wave Therapy for Erectile Dysfunction
Platelet-Rich Plasma, Low-Intensity Extracorporeal Shock Wave Therapy - Erectile Dysfunction
Not applicableNot yet recruitingBenha University802026-09-012026-08-24
Tractography-Guided Nerve-Sparing in Prostate Cancer
Prostate Tractography for Nerve-Sparing - Prostate Cancer, Erectile Dysfunction Following Radical Prostatectomy
Not applicableRecruitingMassimo Valerio232026-09-012026-09-29
Efficacy of Intracavernosal Xeomin With Tadalafil for Mild-Moderate Erectile Dysfunction
IncobotulinumtoxinA (100 Units), Placebo, Tadalafil 20 MG - Erectile Dysfunction
Phase 2Not yet recruitingNorthwestern University302026-09-012026-08-14
Multimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical Prostatectomy
Tadalafil 5 mg, Pelvic Floor Muscle Training (PFMT), Aerobic Exercise Program - Erectile Dysfunction Following Radical Prostatectomy, Prostate Cancer
Phase 2RecruitingSurgical Outcomes Research Centre (SOuRCe)642026-08-312026-10-23
Male Sexual Function and Sexual Quality of Life in Polygamous Versus Monogamous Marriages
Monogamous marital structure, Polygamous marital structure - Erectile Dysfunction, Sexual Dysfunction
RecruitingAl-Azhar University18202026-08-202026-08-25
AIM-TEST: Microbiome-Targeted Nutrition for Functional Secondary Hypogonadism
Fixed-Formula Microbiome-Targeted Oral Nutritional Supplement, Matched Oral Placebo - Hypogonadism, Male, Secondary Hypogonadism
Not applicableEnrolling by invitationVarol TUNALI1122026-08-152026-09-29
Lifestyle Modification for Erectile Dysfunction in Men With Metabolic Syndrome
Structured Lifestyle Modification Program - Erectile Dysfunction, Metabolic Syndrome
Not applicableRecruitingAl-Azhar University552026-08-132026-08-14
Daily Tadalafil as Adjunctive Therapy Versus Monotherapy for PDE5 Inhibitor-Resistant Erectile Dysfunction
Tadalafil; Current on-demand PDE5 inhibitor, Tadalafil 5 mg - Erectile Dysfunction, Tadalafil
Phase 4RecruitingAl-Azhar University2602026-08-132026-09-01
Diagnostic Performance of a Flexible Penile Monitoring System for ED
Intelligent Flexible Penile Monitoring System, RigiScan Plus - Erectile Dysfunction
Not yet recruitingBin Xu602026-08-012026-08-13
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Viaca (Sildenafil + Cabergoline) Compared With Sildenafil and Cabergoline
Viaca, Sildenafil 50 mg, Cabergoline 0.5 MG - Erectile Dysfunctions, Healthy Volunteer
Phase 1Not yet recruitingYanping Kong302026-08-012026-07-28

Showing 20 of 671. Sign in to see all of them.

Narrower conditions

Prostatic Neoplasms (52)  ·  Sexual Dysfunction, Physiological (41)  ·  Urinary Incontinence (21)  ·  Prostatic Hyperplasia (20)  ·  Premature Ejaculation (18)  ·  Diabetes Mellitus (15)  ·  Hypogonadism (13)  ·  Sexual Dysfunctions, Psychological (13)  ·  Hypertension (11)  ·  Lower Urinary Tract Symptoms (11)  ·  Metabolic Syndrome (11)  ·  Spinal Cord Injuries (11)  ·  Diabetes Mellitus, Type 2 (10)  ·  Cardiovascular Diseases (9)

Broader conditions

Genital Diseases (671)  ·  Genital Diseases, Male (671)  ·  Urogenital Diseases (671)  ·  Mental Disorders (670)  ·  Male Urogenital Diseases (668)  ·  Sexual Dysfunctions, Psychological (658)  ·  Sexual Dysfunction, Physiological (630)  ·  Prostatic Diseases (70)  ·  Pathological Conditions, Signs and Symptoms (66)  ·  Neoplasms (62)  ·  Neoplasms by Site (60)  ·  Urogenital Neoplasms (55)  ·  Genital Neoplasms, Male (53)  ·  Signs and Symptoms (50)  ·  Endocrine System Diseases (44)

Interventions

Tadalafil (80)  ·  Sildenafil Citrate (76)  ·  Vardenafil Dihydrochloride (58)  ·  avanafil (17)  ·  udenafil (12)  ·  Extracorporeal Shockwave Therapy (10)  ·  dapoxetine (7)  ·  2-(5-(4-(2-hydroxyethyl)piperazin-1-ylsulfonyl)-2-n-propoxyphenyl)-5-ethyl-7-n-propyl-3,5-dihydro-4H-pyrrolo(3,2-d)pyrimidin-4-one dihydrochloride (6)  ·  Exercise (6)  ·  Sodium Chloride (6)  ·  Surveys and Questionnaires (6)  ·  Tamsulosin (6)  ·  Alprostadil (5)  ·  Ethanol (5)  ·  Phosphodiesterase 5 Inhibitors (5)

Sponsors

Bayer (51)  ·  Eli Lilly and Company (28)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (27)  ·  Cairo University (16)  ·  VIVUS LLC (15)  ·  Rambam Health Care Campus (14)  ·  Vigonvita Life Sciences (10)  ·  Institute for the Study of Urological Diseases, Greece (7)  ·  Pfizer (7)  ·  Hanmi Pharmaceutical Company Limited (6)  ·  Mayo Clinic (6)  ·  SK Chemicals Co., Ltd. (6)  ·  Aspargo Labs, Inc (5)  ·  Benha University (5)  ·  Johns Hopkins University (5)

Countries

United States (173)  ·  Egypt (52)  ·  China (39)  ·  Italy (33)  ·  South Korea (31)  ·  France (30)  ·  Germany (29)  ·  Canada (28)  ·  Spain (28)  ·  Turkey (Türkiye) (28)  ·  United Kingdom (25)  ·  Israel (24)  ·  Brazil (22)  ·  Netherlands (19)  ·  Denmark (17)

Top investigators

Ilan Gruenwald, MD (6)  ·  Dimitrios Hatzichristou, Prof. (5)  ·  Shiyin Yee, PhD (5)  ·  Ali Ismail, lecturer (4)  ·  Herman Ellman, MD (4)  ·  Hui Jiang (4)  ·  Mohit Khera, MD (4)  ·  Ali MA Ismail, lecturer (3)  ·  Chungsu Kim, Ph.D (3)  ·  Irwin Goldstein, MD (3)

Results publications

PMID 24119319, PMID 25974235, PMID 28892218, PMID 23035781, PMID 38224135, PMID 20412423, PMID 20451317, PMID 21059176, PMID 21883954, PMID 24447534, PMID 34326007, PMID 36353027, PMID 10524880, PMID 10636261, PMID 10706155, PMID 10853004, PMID 10869326, PMID 10922975, PMID 10987609, PMID 11121838, PMID 11259809, PMID 11489726, PMID 11557915, PMID 11560536, PMID 11596671, PMID 12145231, PMID 12591819, PMID 14622500, PMID 14713808, PMID 15055866, PMID 15206495, PMID 15210604, PMID 15213209, PMID 15310998, PMID 15592069, PMID 15875061, PMID 16432091, PMID 16528082, PMID 16998234, PMID 17296414, PMID 17452989, PMID 17887993, PMID 18597830, PMID 19143915, PMID 19195772, PMID 19365010, PMID 19473458, PMID 19698065, PMID 19817982, PMID 19837434

NIH funding

2004 (2), 2008 (2), 2009 (2), 2018 (1), 2019 (1), 2023 (1), 2025 (1), R01CA122704 (1), R01CA218657 (1), R01DK077954 (1), R01DK130991 (1), R01HD047722 (1), U10CA081851 (1)